Healthcare
Frontage Holdings Corporation(FGHQF)
Live Price
Offline$0.11
+0.00% today
1Y Change
+38.61%
Window
Jun 26, 2025 โ Jun 23, 2026
- Market Cap
- $260.00M
- Revenue Growth
- +0.8%
- EPS Growth
- +750.0%
- Dividend Yield
- 0.0%
Coverage: 254 bars ยท Jun 26, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Frontage Holdings Corporation (FGHQF) is a Healthcare stock with a market cap of $260.00M and listed on OTC. The stock last traded around $0.11 and up 38.6% across the available one-year price window (Jun 26, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +0.8%, EPS growth of +750.0%, a dividend yield of 0.0%. What stands out right now is revenue +0.8%, EPS +750.0%, free cash flow +114.6% with operating margin 5.7% and ROIC 1.7%. Valuation already assumes a fairly strong business story at P/E 37.6 and price/sales 1.0. Stock Foundry combines FGHQF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+0.8% vs +7.6% peer median
Operating Margin
Below sector median
+5.7% vs +19.4% peer median
P/E
Near sector median
37.6 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report was closer to in-line
2026 was reported on Mar 30, 2026 with revenue ahead of estimates by +0.4%.
The operating story is still moving forward
Revenue is running at +0.8% and EPS at +750.0%, with operating margin around 5.7%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 20, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 30, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Aug 28, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Mar 27, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
FGHQF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
FGHQF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
FGHQF Max Drawdown
-27.63%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for FGHQF and SPY.
Company Overview
Frontage Holdings Corporation
Other OTC
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services that include study designs, execution of studies, and interpretation of the data through structural optimization in early discovery, pharmacokinetic studies in rodents, non- GLP bioanalytical studies, etc. The company also provides safety and toxicology services comprising in-vitro and in-vivo studies; bioequivalence services, which consist of designing, coordinating, and reporting of bioequivalence studies; chemistry services comprising contract research and custom synthesis services; and clinical services, such as early stage clinical, BE/BA, biometric, and data management services. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited.
- Leadership
- Zhongping Lin
- IPO Date
- Apr 14, 2020
- Employees
- 1.6k
- Street Address
- 700 Pennsylvania Drive
- Mailing
- Exton, PA, 19341
- Region
- Exton, PA, US
- Reporting Currency
- USD
- Investor Line
- 610 232 0100
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 37.6
- EV/EBITDA
- 7.8
- Price/Sales
- 1.0
- Price/Book
- 0.7
Growth
- Revenue
- +0.8%
- EPS
- +750.0%
- Free Cash Flow
- +114.6%
Profitability
- Gross Margin
- 27.0%
- Operating Margin
- 5.7%
- Net Margin
- 2.6%
- ROE
- 2.0%
- ROIC
- 1.7%
Balance Sheet
- Debt/Equity
- 0.37
- Current Ratio
- 1.33
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.